ScenPro to convert FDA cross-center clinical data for comparisons

Female-owned and Texas-based ScenPro has landed a contract to convert legacy FDA clinical trial data into standardized formats. The goal of the effort, which encompasses the varied databases that cross the drug, biologics and device centers, is to aid comparative effectiveness research. ScenPro will work with consultancy Octagon Research to convert the data to such standard formats as CDISC for analysis and for merging with data from new and ongoing trials. ScenPro release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.